Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04563793 · ClinicalTrials.gov registry record
Postmarket Outcomes Study for Evaluation of the Superion™ Spacer
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 129
- Enrollment target
NCT04563793 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 129 participants.
The verdict
NCT04563793 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 129 participants
- Enrollment target
Study Summary
To compile real-world outcomes of the Superion™ IDS in routine clinical practice.
Interventions
- DEVICE Superion™ IDS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2020-10-08 |
| Est. Completion | 2023-03-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04563793
The ClinicalTrials.gov registry entry for NCT04563793 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Superion™ IDS is the first listed.
NCT04563793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04563793 about?
NCT04563793 is a clinical study titled "Postmarket Outcomes Study for Evaluation of the Superion™ Spacer". To compile real-world outcomes of the Superion™ IDS in routine clinical practice.
What is the current status of trial NCT04563793?
This trial is currently completed. The enrollment target is 129 participants. The study started on 2020-10-08. Estimated completion is 2023-03-20.
What interventions are being tested in trial NCT04563793?
The interventions under investigation include: Superion™ IDS (DEVICE).
Who is sponsoring clinical trial NCT04563793?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.